RGEN

163.8103.81%
NM

Nicholas M. Barthelemy

Independent Director

Mr. Nicholas M. Barthelemy, also known as Nicolas, served as Chairman of the Board at NanoCellect Biomedical, Inc until 2025. He has been Non-Employee Director of Twist Bioscience Corporation since October 24, 2019 until February 07, 2023. He served as an Independent Director 908 Devices Inc. since February 2018 until June 2022. He is Executive Chair at Slingshot Biosciences, Inc. since January 2024 and serves as its Director. He serves as a Director of NanoCellect Biomedical, Inc. Mr. Barthelemy has been an Independent Director of Repligen Corporation since June 10, 2014. He served as a Director of Standard BioTools Inc. (formerly known as Fluidigm Corporation) since March 2017 until April 05, 2022. He serves as Director of Biocare Medical and Limited Liability Company. Mr. Barthelemy currently serves as an advisor to Warburg Pincus. He serves as Director of Genewiz. He was Senior Advisor at Mrieux Developpement SAS since joining in March 2016 till October 2018. He was a Regional Partner at Mrieux Equity Partners SAS till 2019. Prior to this, he was the Chief Executive Officer and President of BioTheranostics, Inc. from September 2014 to February 2017. Mr. Barthelemy served as the President of Commercial Operations at Life Technologies Corporation from 2010 to 2013. He served as Director of Avantor and Essen Holdings, Inc. He served as the President of Cell Systems at Life Technologies Corporation from November 2008 to January 1, 2011. He led Invitrogen's Cell Systems since January 2006. He served as Senior Vice President of Global Operations from March 2004 to January 2006. Previously, he served as President, Global Commercial Operations at Life Technologies Corporation, a global life sciences company, which was acquired by Thermo Fisher Scientific Incorporated in February 2014. Prior to joining Invitrogen, he was with Biogen Idec MA Inc., for few years from 1996 to 2004 and held several executive positions including Vice President of Manufacturing and General Manager for manufacturing organization at Research Triangle Park. He began his career with Merck & Co., Inc. as a Senior Project Engineer of Vaccine Technology. Mr. Barthelemy is a recognized Operations Leader in large-scale mammalian cell culture and purification. He served as a Director of BioTheranostics, Inc. He served as a Director at Essen Bioscience. He served as a Director of Biomatrica, Inc. since June 2014. Mr. Barthelemy received his M.S. in Chemical Engineering from the University of California, Berkeley in 1991. He received the equivalent of an M.S. in Chemistry from Ecole Supérieure de Physique et Chimie Industrielles (Paris, France) in 1989 and the equivalent of a B.S. in Mathematics, Physics and Chemistry from Ecole Supérieure de Physique et Chimie Industrielles, Paris. He also attended Harvard Business School's Program for Management Development.

Positions